U.S. stocks opened mixed after a volatile premarket session Tuesday after public health agencies announced a temporary halt in the use of a COVID-19 vaccine from Johnson & Johnson and inflation was stronger than analysts had forecast in March. The Dow Jones Industrial Average
DJIA,
-0.34%
fell 62 points, 0.2%, to open near 33,684, while the S&P 500
SPX,
+0.12%
gained 1 point to open near 4,129. The Nasdaq Composite index
COMP,
+0.68%,
which contains many of the stocks most in favor in a work-from-home world, added 65 points, 0.5%, to start trading near 13,915. Johnson & Johnson shares
JNJ,
-1.89%
slipped 2.4% after the opening bell. In other biotech news, shares of Novocure Ltd.
NVCR,
+58.70%
skyrocketed after the tumor treatment company reported positive news on its lung cancer treatment. The consumer price index gained 2.6% for the year in March, the Labor Department said.
